BioSyent Inc. (TSXV: RX)
Canada
· Delayed Price · Currency is CAD 11.25
-0.05 (-0.44%)
Nov 21, 2024, 10:43 AM EST
BioSyent Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 34.51 | 31.59 | 27.93 | 28.62 | 22.33 | 21.42 | Upgrade
|
| Revenue Growth (YoY) | 12.12% | 13.12% | -2.42% | 28.15% | 4.24% | -0.48% | Upgrade
|
| Cost of Revenue | 7.1 | 5.99 | 5.07 | 5.98 | 4.91 | 4.78 | Upgrade
|
| Gross Profit | 27.41 | 25.6 | 22.86 | 22.64 | 17.42 | 16.65 | Upgrade
|
| Selling, General & Admin | 19.13 | 18.13 | 15.88 | 14.45 | 12.39 | 10.39 | Upgrade
|
| Operating Expenses | 19.13 | 18.13 | 15.88 | 14.45 | 12.39 | 10.39 | Upgrade
|
| Operating Income | 8.28 | 7.47 | 6.98 | 8.18 | 5.03 | 6.26 | Upgrade
|
| Interest Expense | -0.06 | -0.07 | -0.08 | -0.09 | -0.09 | -0.03 | Upgrade
|
| Interest & Investment Income | 1.13 | 1.13 | 0.53 | 0.16 | 0.26 | 0.45 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.04 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | 9.39 | 8.53 | 7.43 | 8.25 | 5.24 | 6.74 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.87 | Upgrade
|
| Other Unusual Items | - | - | - | 0.13 | - | - | Upgrade
|
| Pretax Income | 9.39 | 8.53 | 7.43 | 8.38 | 5.24 | 5.87 | Upgrade
|
| Income Tax Expense | 2.28 | 2.07 | 1.97 | 2.1 | 1.44 | 1.5 | Upgrade
|
| Net Income | 7.11 | 6.46 | 5.46 | 6.28 | 3.8 | 4.37 | Upgrade
|
| Net Income to Common | 7.11 | 6.46 | 5.46 | 6.28 | 3.8 | 4.37 | Upgrade
|
| Net Income Growth | 14.48% | 18.35% | -13.11% | 65.51% | -13.14% | -23.42% | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 13 | 13 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 13 | 13 | 13 | 14 | Upgrade
|
| Shares Change (YoY) | -3.05% | -2.95% | -2.57% | -1.70% | -6.10% | -4.06% | Upgrade
|
| EPS (Basic) | 0.61 | 0.54 | 0.44 | 0.50 | 0.29 | 0.31 | Upgrade
|
| EPS (Diluted) | 0.60 | 0.53 | 0.43 | 0.49 | 0.29 | 0.31 | Upgrade
|
| EPS Growth | 18.15% | 22.07% | -10.86% | 68.28% | -6.45% | -20.51% | Upgrade
|
| Free Cash Flow | 6.65 | 5 | 4.9 | 4.59 | 6.88 | 3.9 | Upgrade
|
| Free Cash Flow Per Share | 0.56 | 0.41 | 0.39 | 0.36 | 0.53 | 0.28 | Upgrade
|
| Dividend Per Share | 0.160 | 0.160 | 0.040 | - | - | - | Upgrade
|
| Dividend Growth | 300.00% | 300.00% | - | - | - | - | Upgrade
|
| Gross Margin | 79.42% | 81.03% | 81.85% | 79.10% | 78.02% | 77.70% | Upgrade
|
| Operating Margin | 23.99% | 23.65% | 25.00% | 28.59% | 22.52% | 29.21% | Upgrade
|
| Profit Margin | 20.60% | 20.45% | 19.55% | 21.95% | 16.99% | 20.39% | Upgrade
|
| Free Cash Flow Margin | 19.28% | 15.81% | 17.55% | 16.04% | 30.81% | 18.19% | Upgrade
|
| EBITDA | 8.59 | 7.76 | 7.26 | 8.47 | 5.37 | 6.46 | Upgrade
|
| EBITDA Margin | 24.89% | 24.58% | 26.01% | 29.60% | 24.04% | 30.14% | Upgrade
|
| D&A For EBITDA | 0.31 | 0.29 | 0.28 | 0.29 | 0.34 | 0.2 | Upgrade
|
| EBIT | 8.28 | 7.47 | 6.98 | 8.18 | 5.03 | 6.26 | Upgrade
|
| EBIT Margin | 23.99% | 23.65% | 25.00% | 28.59% | 22.52% | 29.21% | Upgrade
|
| Effective Tax Rate | 24.28% | 24.30% | 26.54% | 25.03% | 27.53% | 25.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.